Medical devices, healthcare technology and the business of care
510(k) clearance · K254238

MINT MONO Sutures

Hans Biomed Corporation · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONK254238

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for MINT MONO Sutures, submitted by Hans Biomed Corporation of Yuseong-Gu, Korea, under 510(k) number K254238. The application was received on 12/29/2025 and decided on 09/18/2026. The device falls under the classification name Suture, Surgical, Absorbable, Polydioxanone, regulation number 878.4840, with the General & Plastic Surgery medical specialty and review panel. The classification product code is listed as NEW.

The submission was a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. SESE means FDA cleared the device as substantially equivalent to a predicate; it is not a PMA approval. The public record does not state the predicate device, the specific indications for use, or the materials and sizes covered, so those details remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 18, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254238
Regulatory pathway
510(k) premarket notification
Product code
NEW
Decision code
SESE
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Suture, Surgical, Absorbable, Polydioxanone.

Product code
NEW
FDA device class
2

FDA decision timeline

  1. K254238 received

    Application receipt date recorded by FDA.

  2. K254238 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Hans Biomed Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Yuseong-Gu

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records